Top section
Top section
High yields and tight senior/sub spread fuel enthusiasm for issuance among investors and issuers
◆ Pair help market to end week on a high note ◆ GSK offers pick-up over peer AstraZeneca ◆ Glencore finds demand at eight years
◆ French borrower takes €1.15bn across two tranches ◆ Balance struck between size and price to keep investors onside ◆ Small concession offered
Data
More articles
More articles
More articles
-
Kevin Duignan to retire after 33 years, mainly in structured finance
-
-
Crédit Agricole and DekaBank take centre stage in Swissies as domestic names go quiet
-
Calendar quirk could keep issuance going in December
-
Light opportunistic dusting expected, but prohibitive pricing to put off non-sterling funders
-
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
Sub-sections